Syntec Optics (Nasdaq: OPTX) to Display Innovations at Photonics West 2024

Showcasing Groundbreaking Defense, Biomedical, Consumer and Communications Technology

ROCHESTER, NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a scientific and technical instrument, and aerospace and defense optics provider, gears up for a dynamic presence at Photonics West 2024, taking place January 30 – February 1, 2024, in San Francisco, California. At booth #143, Syntec Optics will demonstrate its latest breakthroughs, engage with valued customers, and ignite further partnerships within the vibrant photonics community.

"Photonics West serves as a pivotal platform for us to showcase our cutting-edge innovations and connect with industry leaders driving the future of light-based technologies," says Joe Mohr, CEO of Syntec Optics. "We are eager to demonstrate the versatility and impact of our diverse portfolio, ranging from defense applications to the frontiers of biomedical optics."

Syntec Optics looks forward to engaging in productive discussions with existing blue-chip customers, fostering stronger collaborations, and exploring new opportunities for growth. Additionally, the team will be available to address inquiries from potential partners and customers, paving the way for future collaborations and advancements within the optics and photonics marketplace.

Photonics West attendees will witness a display of Syntec Optics' latest offerings: 

  • Phoenix Thermal Clip-on Scope: Experience enhanced situational awareness in low-light conditions with this groundbreaking thermal clip-on scope. 
  • 3X Magnifier for Defense Sights: Soldiers can increase precision and target acquisition with this reshored compact and reliable magnifier made in America. 
  • Viper Lightweight Eyepiece and Objective Lenses for Night Vision Goggles: Enhance user comfort and operational efficiency with these innovative, lightweight lens systems. 
  • Microlens Arrays for Fiber Optics Coupling and Biomedical Applications: Discover unparalleled precision and efficiency in light manipulation with these advanced microlens arrays. 
  • Ultra-Precision Biomedical Optics: Revolutionize medical imaging and diagnostics with Syntec Optics' state-of-the-art biomedical optics solutions. 
  • Gold Thin Film Coating: Unveil high optical performance and superior durability with Syntec Optics' cutting-edge gold thin film coating technology.

You can visit Syntec Optics at the large booth #143 during Photonics West 2024 to immerse yourself in a world of transformative light-based technologies. Witness firsthand the company's dedication to innovation, customer collaboration, and pushing the boundaries of what's possible. 

About Syntec Optics 

Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a 20-year optics and photonics leader for scientific and technical instruments and aerospace and defense products, has the mission of keeping American soldiers out of harm's way, improving patient care and bringing more precision products to the consumer and communications. Syntec Optics, headquartered in Rochester, NY, is one of the largest custom optics and photonics manufacturers in the United States. Operating for over two decades, Syntec Optics runs a state-of-the-art manufacturing facility with extensive core capabilities of various optics manufacturing processes, both horizontally and vertically integrated, to provide a competitive advantage for mission-critical OEMs. Syntec Optics recently launched new products, including Low Earth Orbit (LEO) satellite optics, lightweight night vision goggle optics, biomedical equipment optics, and precision microlens arrays. To learn more, visit 

Cautionary Note Regarding Forward-Looking Statements 

This press release contains certain “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended, including certain financial forecasts and projections. All statements other than statements of historical fact contained in this press release, including statements as to the transactions contemplated by the business combination and related agreements, future results of operations and financial position, revenue and other metrics, planned products and services, business strategy and plans, objectives of management for future operations of Syntec Optics, market size, and growth opportunities, competitive position and technological and market trends, are forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “plan,” “targets,” “projects,” “could,” “would,” “continue,” “forecast” or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors (some of which are beyond the control of Syntec Optics), which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts and assumptions that, while considered reasonable by Syntec Optics and its management, as the case may be, are inherently uncertain and many factors may cause the actual results to differ materially from current expectations which include, but are not limited to: 1) risk outlined in any prior SEC filings; 2) ability of Syntec Optics to successfully increase market penetration into its target markets; 3) the addressable markets that Syntec Optics intends to target do not grow as expected; 4) the loss of any key executives; 5) the loss of any relationships with key suppliers including suppliers abroad; 6) the loss of any relationships with key customers; 7) the inability to protect Syntec Optics’ patents and other intellectual property; 8) the failure to successfully execute manufacturing of announced products in a timely manner or at all, or to scale to mass production; 9) costs related to any further business combination; 10) changes in applicable laws or regulations; 11) the possibility that Syntec Optics may be adversely affected by other economic, business and/or competitive factors; 12) Syntec Optics’ estimates of its growth and projected financial results for the future and meeting or satisfying the underlying assumptions with respect thereto; 13) the impact of any pandemic, including any mutations or variants thereof and the Russian/Ukrainian or Israeli conflict, and any resulting effect on business and financial conditions; 14) inability to complete any investments or borrowings in connection with any further business combination; 15) the potential for events or circumstances that result in Syntec Optics’ failure to timely achieve the anticipated benefits of Syntec Optics’ customer arrangements; and 16) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in prior SEC filings including registration statement on Form S-4 filed with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Syntec Optics does not give any assurance that Syntec Optics will achieve its expected results. Syntec Optics does not undertake any duty to update these forward-looking statements except as otherwise required by law. 

For further information, please contact: 

Sara Hart

Investor Relations 

SOURCE: Syntec Optics Holdings, Inc. (Nasdaq: OPTX)